Jason Bondoc Alipio

Jason Bondoc Alipio

Auto-generated profile, based on publicly available information

Jason Bondoc Alipio

Department of Anatomy & Neurobiology, Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2021 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JAJason B. Alipio
Jason B. Alipio
CHCatherine Haga
Catherine Haga
MFMegan E. Fox
Megan E. Fox
KAKeiko Arakawa
Keiko Arakawa
RBRakshita Balaji
Rakshita Balaji
AKAsaf Keller
Asaf Keller
One consequence of the opioid epidemic are lasting neurodevelopmental sequelae afflicting adolescents exposed to opioids in the womb. A translationally relevant and developmentally accurate preclinical model is needed to understand the behavioral, circuit, network, and molecular abnormalities resulting from this exposure. By employing a novel preclinical model of perinatal fentanyl exposure, our data reveal that fentanyl has several dose-dependent, developmental consequences to somatosensory function and behavior. Newborn male and female mice exhibit signs of withdrawal and sensory-related deficits that extend at least to adolescence. As fentanyl exposure does not affect dams' health or maternal behavior, these effects result from the direct actions of perinatal fentanyl on the pups' developing brain. At adolescence, exposed mice exhibit reduced adaptation to sensory stimuli, and a corresponding impairment in primary somatosensory (S1) function. In vitro electrophysiology demonstrates a long-lasting reduction in S1 synaptic excitation, evidenced by decreases in release probability, NMDA receptor-mediated postsynaptic currents, and frequency of miniature excitatory postsynaptic currents (mEPSCs), as well as increased frequency of miniature inhibitory postsynaptic currents (mIPSCs). In contrast, anterior cingulate cortical neurons exhibit an opposite phenotype, with increased synaptic excitation. Consistent with these changes, electrocorticograms (ECoGs) reveal suppressed ketamine-evoked γ oscillations. Morphologic analysis of S1 pyramidal neurons indicate reduced dendritic complexity, dendritic length, and soma size. Further, exposed mice exhibited abnormal cortical mRNA expression of key receptors involved in synaptic transmission and neuronal growth and development, changes that were consistent with the electrophysiological and morphologic changes. These findings demonstrate the lasting sequelae of perinatal fentanyl exposure on sensory processing and function. SIGNIFICANCE STATEMENT This is the first study to show that exposure to fentanyl in the womb results in behavioral, circuitry, and synaptic effects that last at least to adolescence. We also show, for the first time, that this exposure has different, lasting effects on synapses in different cortical areas.

18 March 2020 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
JAJason B. Alipio
Jason B. Alipio
ABAdam T. Brockett
Adam T. Brockett
MFMegan E. Fox
Megan E. Fox
STStephen S. Tennyson
Stephen S. Tennyson
CDCoreylyn A. Debettencourt
Coreylyn A. Debettencourt
AKAsaf Keller
Asaf Keller

15 August 2019 in bioRxiv
Verified
Preprint
Open access
JAJason B. Alipio
Jason B. Alipio
ABAdam T. Brockett
Adam T. Brockett
MFMegan E. Fox
Megan E. Fox
STStephen S. Tennyson
Stephen S. Tennyson
CDCoreylyn A. Debettencourt
Coreylyn A. Debettencourt
AKAsaf Keller
Asaf Keller
Opioid use by pregnant women is an understudied consequence associated with the opioid epidemic, resulting in a rise in the incidence of neonatal opioid withdrawal syndrome (NOWS), and lifelong neurobehavioral deficits that result from perinatal opioid exposure. There are few preclinical models that accurately recapitulate human perinatal drug exposure, and few focus on fentanyl, a potent synthetic opioid that is a leading driver of the opioid epidemic. To investigate the consequences of perinatal opioid exposure, we administered fentanyl to mouse dams in their drinking water throughout gestation and until litters were weaned at postnatal day (PD) 21. Fentanyl-exposed dams delivered smaller litters, and had higher litter mortality rates compared to controls. Metrics of maternal care behavior were not affected by the treatment, nor were there differences in dams’ weight or liquid consumption throughout gestation and 21 days postpartum. Twenty-four hours after weaning and drug cessation, perinatal fentanyl-exposed mice exhibited signs of spontaneous somatic withdrawal behavior, and sex-specific weight fluctuations that normalized in adulthood. At adolescence (PD 35) they displayed elevated anxiety-like behaviors and decreased grooming, assayed in the elevated plus maze and sucrose splash tests. Finally, by adulthood (PD 55) they displayed impaired performance in a two-tone auditory discrimination task. Collectively, our findings suggest that perinatal fentanyl exposed mice exhibit somatic withdrawal behavior and changes across the lifespan reminiscent of humans born with NOWS.

20 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJason B. Alipio
Jason B. Alipio
CHCatherine Haga
Catherine Haga
MFMegan E Fox
Megan E Fox
KAKeiko Arakawa
Keiko Arakawa
RBRakshita Balaji
Rakshita Balaji
AKAsaf Keller
Asaf Keller
One consequence of the opioid epidemic are the lasting neurodevelopmental sequelae afflicting children and adolescents exposed to opioids in the womb. The gravity of these consequences is further amplified by the COVID-19 pandemic, in which the use of synthetic opioids, including fentanyl, has increased among pregnant women. A translationally relevant and developmentally accurate preclinical model is needed to understand the behavioral, circuit, network, and molecular abnormalities resulting from fentanyl use during pregnancy. By employing a novel preclinical model of perinatal fentanyl exposure, our data reveal that fentanyl has several dose-dependent, developmental consequences to somatosensory function and behavior. First, newborn mice exhibit signs of withdrawal, and sensory-related deficits that extend at least to adolescence. As fentanyl exposure does not affect dams’ health or maternal behavior, these effects appear to result from the direct actions of perinatal fentanyl on the pups’ developing brain. At adolescence, exposed mice exhibited reduced adaptation to sensory stimuli, and a corresponding impairment in primary somatosensory (S1) function. Our in vitro electrophysiology data demonstrate that perinatal fentanyl leads to a long-lasting reduction in S1 synaptic excitation, as evidenced by decreases in excitatory release probability, NMDA receptor-mediated postsynaptic currents, and frequency of miniature excitatory postsynaptic currents, as well as increased frequency of miniature inhibitory postsynaptic currents. In contrast, anterior cingulate cortical neurons exhibit an opposite phenotype, with increased synaptic excitation in perinatal fentanyl exposed mice. Consistent with these synaptic changes, analysis of electrocorticograms revealed that exposed adolescent mice exhibited suppressed ketamine-evoked γ oscillations. Morphological analysis of S1 pyramidal neurons from exposed mice indicate reduced dendritic complexity, dendritic length, and soma size. Further, exposed mice exhibited abnormal cortical mRNA expression of key receptors involved in synaptic transmission and neuronal growth and development, changes that were consistent with the electrophysiological and morphological changes. These findings demonstrate the lasting sequela of perinatal fentanyl exposure on sensory processing and function.

2 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJason Bondoc Alipio
Jason Bondoc Alipio
LRLace Marie Riggs
Lace Marie Riggs
MPMadeline Plank
Madeline Plank
AKAsaf Keller
Asaf Keller
The opioid epidemic is a rapidly evolving societal issue driven, in part, by a surge in synthetic opioid use. A rise in fentanyl use among pregnant women has led to a 40-fold increase in the number of perinatally-exposed infants in the past decade. These children are more likely to develop mood- and somatosensory-related conditions later in life, suggesting that fentanyl may permanently alter neural development. Here, we examined the behavioral and synaptic consequences of perinatal fentanyl exposure in adolescent male and female C57BL/6J mice and assessed the therapeutic potential of environmental enrichment to mitigate these effects. Dams were given ad libitum access to fentanyl (10 µg/mL, per os ) across pregnancy and until weaning (PD 21). Perinatally-exposed adolescent mice displayed hyperactivity (PD 45), enhanced sensitivity to anxiogenic environments (PD 46), and sensory maladaptation (PD 47) – sustained behavioral effects that were completely normalized by environmental enrichment (PD 21-45). Additionally, environmental enrichment normalized the fentanyl-induced changes in the frequency of miniature excitatory postsynaptic currents of layer 2/3 neurons in the primary somatosensory cortex (S1). We also demonstrate that fentanyl impairs short- and long-term potentiation in S1 layer 2/3 neurons which, instead, exhibit a sustained depression of synaptic transmission that is restored by environmental enrichment. On its own, environmental enrichment suppressed long-term depression of control S1 neurons from vehicle-treated mice subjected to standard housing conditions. These results demonstrate that the lasting effects of fentanyl can be ameliorated with a non-invasive intervention introduced during early development. Significance Statement: Illicit use of fentanyl accounts for a large proportion of opioid-related overdose deaths. Children exposed to opioids during development have a higher risk of developing neuropsychiatric disorders later in life. Here, we employ a preclinical model of perinatal fentanyl exposure that recapitulates these long-term impairments and show, for the first time, that environmental enrichment can reverse deficits in somatosensory circuit function and behavior. These findings have the potential to directly inform and guide ongoing efforts to mitigate the consequences of perinatal opioid exposure.